Traditional Chinese medicine composition for treating burn and preparation method thereof
The existing burns were solved by using traditional Chinese medicine compositions of cypress, forsythia, dandelion, cypress, centipede and borneol, combined with extraction and soaking techniques, and burn ointment with stronger healing and anti-inflammatory effects. The problem of insufficient cream effect provides a safer and more effective treatment plan.
Patent Information
- Application Number
- CN202411250093.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-06
- Publication Date
- 2024-11-12
AI Technical Summary
There is still room for improvement in the existing burn ointment in terms of promoting healing and anti-inflammatory effects. There are adverse reactions in Western medicine when treating burns and scalds, while the traditional Chinese medicine composition has little drug resistance and insufficient clinical application.
Using a traditional Chinese medicine composition, including cypress, forsythia, honeysuckle, dandelion, cypress, centipede and borneol, the extract is prepared by soaking and heating extraction method with grease, and combined with the ethanol immersion step, to form a paste or other topical preparation , used to treat burns.
This traditional Chinese medicine composition significantly improves the effects of burn ointment to clear heat and detoxify, reduce swelling and pain, promote blood circulation and muscle production, promote wound healing, shorten the healing cycle, reduce trauma area, and reduce adverse reactions, providing a safer treatment plan.
Smart Images

Figure CN118924822A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of traditional Chinese medicines, and in particular to a traditional Chinese medicine composition for treating burns and a preparation method thereof. Background Art
[0002] Burns and scalds are the fourth most common type of trauma in the world. They are caused by the action of boiling water (oil), fire, light, electricity, radiation or chemical substances on the human body. At present, there are many kinds of drugs used to treat burns and scalds, which can be basically divided into Chinese medicine and Western medicine. Western medicine is widely used in the treatment of burns and scalds, but the raw materials of Western medicine are mostly chemical substances, with single efficacy and obvious adverse reactions. For example, long-term use of silver sulfadiazine can cause neutropenia and nephrotoxicity. Chinese medicine compositions have multi-component, multi-target and multi-effect effects, low drug resistance and adverse reactions, and have certain advantages. Traditional Chinese medicine believes that heat toxicity is the cause of burns and scalds, and heat-clearing and detoxifying drugs are commonly used therapeutic drugs. New Chinese medicine compound therapeutic drugs are often developed based on this, such as moist burn ointment, rhubarb film-forming agent, etc. In recent years, the theoretical level of Chinese medicine external treatment of burns has been continuously improved, clinical experience has been continuously enriched, and clinical advantages have become more and more obvious.
[0003] For example, patent CN201610977511.8 discloses a burn and scald medicine, which includes the following raw materials in parts by weight: 1000-2000 parts of rice, 3-8 parts of safflower, 10-30 parts of angelica, 12-20 parts of yew clover, 8-16 parts of gallwood, 15-25 parts of water centipede, 5000-6000 parts of rice wine, 5000-6000 parts of white rice vinegar, 8-15 parts of phellodendron and 3-8 parts of plum tablets.
[0004] For another example, patent CN201110249919.0 discloses a burn and scald liquid, a burn and scald ointment and a preparation method thereof. The burn and scald liquid is prepared by grinding herbs such as Polygonum cuspidatum, Lithospermum officinale, Raw Gardenia jasminoides, and Raw Phellodendron amurense into powder, then soaking the powder in ethanol for one or two months, filtering the powder before use, and then adding a small amount of musk.
[0005] At present, although the burn ointment on the market can treat general burns, the healing and anti-inflammatory effects still need to be improved. Therefore, it is necessary to improve the existing burn ointment. Summary of the invention
[0006] In view of the deficiencies in the prior art, an object of the present invention is to provide a Chinese medicine composition for treating burns and a preparation method thereof. The Chinese medicine composition has a reasonable compatibility, has better healing and anti-inflammatory effects, and can reduce the wound area more quickly.
[0007] To achieve the above purpose, the technical solution adopted by the present invention is as follows:
[0008] In one aspect, a traditional Chinese medicine composition for treating burns comprises Lithospermum officinale, Forsythia suspensa, Honeysuckle Flos, Taraxacum mongolicum, Phellodendron amurense, Scolopendra subspinipes and Borneol.
[0009] Furthermore, the Chinese medicine composition comprises the following raw materials in parts by weight: 40-85 parts by weight of Lithospermum officinale, 40-85 parts by weight of Forsythia suspensa, 20-65 parts by weight of Honeysuckle, 20-65 parts by weight of Taraxacum officinale, 20-65 parts by weight of Phellodendron amurense, 1-5 parts by weight of Scolopendra subspinipes and 5-25 parts by weight of Borneol.
[0010] Preferably, the Chinese medicine composition comprises the following raw materials in parts by weight: 50-70 parts by weight of Lithospermum officinale, 50-70 parts by weight of Forsythia suspensa, 30-50 parts by weight of Honeysuckle, 30-50 parts by weight of Taraxacum officinale, 30-50 parts by weight of Phellodendron chinense, 1.5-3.5 parts by weight of Scolopendra subspinipes and 10-20 parts by weight of Borneol.
[0011] Further preferably, the Chinese medicine composition comprises the following raw materials in parts by weight: 60 parts by weight of Lithospermum officinale, 60 parts by weight of Forsythia suspensa, 40 parts by weight of Honeysuckle, 40 parts by weight of Taraxacum officinale, 40 parts by weight of Phellodendron chinense, 2.4 parts by weight of Scolopendra subspinipes and 15 parts by weight of Borneol.
[0012] In the prescription, Lithospermum officinale is sweet and salty in nature and cold in nature. It has the functions of cooling blood and activating blood circulation, detoxifying and clearing rashes, and is good at treating water and fire burns; Forsythia suspensa is bitter in nature and cool in nature. It has the functions of clearing heat and detoxifying, reducing swelling and dispersing knots. Both medicines can clear heat and detoxify, dissipate wind-heat, and make the fire and heat evil penetrate the surface. They are used as the main medicine. Honeysuckle is sweet in nature and cold in nature. It has the functions of clearing heat and detoxifying, dispersing wind-heat; Taraxacum officinale is sweet and slightly bitter in nature and cold in nature. It has the functions of clearing heat and detoxifying, reducing swelling and dispersing knots, and diuresis and relieving stranguria; Phellodendron chinense is bitter in nature and cold in nature. It has the functions of clearing heat and drying dampness, purging fire and detoxifying. The combination of the three medicines helps Lithospermum officinale and Forsythia suspensa to clear heat and purge fire, cool blood and detoxify, and they are all ministerial medicines. Borneol is spicy in taste and fragrant in nature and is cold in nature. It has the functions of clearing heat and relieving pain, purging fire and detoxifying, and is used as an assistant. Centipede has the functions of calming wind and calming spasms, attacking toxins and dispersing knots, and dredge meridians to relieve pain. It can strengthen the analgesic function when combined with Borneol, and is also an assistant. The combination of these medicines can clear away heat and detoxify, reduce swelling and relieve pain, and promote blood circulation and tissue regeneration.
[0013] On the other hand, the preparation method of the above-mentioned Chinese medicine composition for treating burns comprises the following steps:
[0014] (1) soaking Lithospermum officinale in oil and heating for extraction to obtain Lithospermum officinale extract;
[0015] (2) taking Forsythia suspensa, honeysuckle, dandelion, Phellodendron chinense and Scolopendra subspinipes, soaking them in water, heating and extracting them to obtain an extract;
[0016] (3) Add the extract obtained in step (2) to the lithospermum officinale extract obtained in step (1), add borneol, and mix well.
[0017] Furthermore, in step (1), the oil is selected from at least one of sesame oil, peanut oil, cottonseed oil and olive oil.
[0018] Furthermore, in step (1), the amount of the oil is 5-10 times the mass of Lithospermum officinale.
[0019] Furthermore, in step (1), the soaking time is 20-40 minutes.
[0020] Furthermore, in step (1), the heating extraction time is 5-20 min, and the heating extraction temperature is 140-160°C, preferably 150°C.
[0021] Furthermore, in step (2), the amount of water used is 6-10 times the total mass of Forsythia suspensa, Honeysuckle, Taraxacum officinale, Phellodendron amurense and Scolopendra subspinipes.
[0022] Furthermore, in step (2), the soaking time is 0.5-1.5h.
[0023] Furthermore, in step (2), during the heating extraction process, the heating temperature is 75-100° C., the number of extractions is 2-3 times, and the time for each extraction is 0.5-2 h.
[0024] Furthermore, the step (2) further comprises an alcohol precipitation step; the alcohol precipitation step is as follows: the extract is concentrated to a clear paste with a relative density of 1.06-1.10 (60° C.), ethanol is added to the clear paste to make the alcohol content reach 60-80%, left for 20-72 hours, filtered, and the ethanol is recovered until there is no alcohol taste, thereby obtaining an alcohol precipitation concentrate.
[0025] Furthermore, in step (3), the borneol is crushed before use.
[0026] On the other hand, an external preparation for treating burns comprises the aforementioned traditional Chinese medicine composition.
[0027] Furthermore, the dosage form of the external preparation is at least one of an ointment, a liniment, a paint, a gel, a film coating, a gel patch, and a lotion.
[0028] Furthermore, the external preparation further comprises at least one of a pharmaceutically acceptable excipient, a matrix and a carrier.
[0029] Furthermore, the auxiliary material is at least one of a moisturizer, a pH adjuster, a disinfectant, a preservative, and an antioxidant.
[0030] Optionally, the moisturizer includes but is not limited to at least one of glycerol, propylene glycol, 1,3-butylene glycol, sorbitol, polyethylene glycol, sodium pyrrolidone carboxylate, hyaluronic acid, lactic acid and sodium lactate. The disinfectant includes but is not limited to at least one of triclosan, parachloro-meta-xylenol, chlorhexidine acetate and polyhexamethylene biguanide.
[0031] Optionally, the pH adjuster includes but is not limited to at least one of boric acid, borax, sodium hydroxide, hydrochloric acid, phosphoric acid / phosphate buffer, acetic acid / acetate buffer, citric acid / citrate buffer, and boric acid / borate buffer.
[0032] Optionally, the preservative includes but is not limited to at least one of sodium benzoate, potassium benzoate, ethanol, sorbic acid, potassium sorbate, propylene glycol, glycerol, isopropyl alcohol or sodium propionate.
[0033] Optionally, the antioxidant includes but is not limited to at least one of sulfite, ascorbic acid, sodium pyrosulfite, glycine, cysteine, ascorbic acid, and sodium thiosulfate.
[0034] Preferably, the matrix includes but is not limited to at least one of a gel skeleton material, an oil phase matrix, and an emulsifier.
[0035] Optionally, the gel skeleton material includes but is not limited to at least one of a carbomer series, a cellulose derivative, and a chitosan matrix.
[0036] The oil phase matrix includes but is not limited to at least one of vegetable oil, higher fatty alcohol, beeswax, stearic acid, lanolin, vaseline, stearyl alcohol, and paraffin.
[0037] Optionally, the selected emulsifier includes but is not limited to at least one of Tween, Span, triethylamine, and stearyl glyceryl.
[0038] Preferably, the carrier includes but is not limited to one or more of an excipient, an antioxidant, a pH adjuster, a preservative, and a flavoring agent.
[0039] Optionally, the excipient includes but is not limited to at least one of mannitol, sorbitol, glucose, sodium chloride, lactose, starch, dextran, cyclodextrin or a cyclodextrin derivative.
[0040] In some specific embodiments, the dosage form of the external preparation is an ointment, and the external preparation comprises the above-mentioned traditional Chinese medicine composition, and excipients and emulsifiers. The external preparation is prepared by the following method:
[0041] Take the oil phase auxiliary materials and emulsifier, heat them to 70-90°C, and after they are completely melted, add the lithospermum oil extract, and mix them to obtain the oil phase; take the water phase auxiliary materials and emulsifier, heat them to 70-90°C, and after they are completely melted, add the extracts extracted from forsythia, honeysuckle, dandelion, phellodendron and centipede to obtain the water phase; at 70-90°C, slowly add the water phase into the oil phase, stir, cool, add borneol powder, and stir evenly to obtain.
[0042] Preferably, the oil phase auxiliary material includes but is not limited to at least one of stearic acid, glyceryl stearate, lanolin, vaseline, stearyl alcohol, paraffin, beeswax, and vegetable oil; the amount of the oil phase auxiliary material is 0.25-1.5 times the mass of the traditional Chinese medicine composition.
[0043] Preferably, the aqueous phase auxiliary material includes but is not limited to at least one of glycerol, sorbitol, water, propylene glycol, and polyethylene glycol; the amount of the aqueous phase auxiliary material is 0.15-0.75 times the mass of the traditional Chinese medicine composition.
[0044] Preferably, the emulsifier includes but is not limited to at least one of Tween, Span and triethylamine; the amount of the emulsifier is 0.03-0.5 times the mass of the traditional Chinese medicine composition.
[0045] Compared with the prior art, the present invention has the following beneficial effects:
[0046] 1. The present invention provides a composition for treating burns, which has the effects of clearing away heat and detoxifying, relieving swelling and relieving pain, and promoting blood circulation and promoting tissue regeneration.
[0047] 2. The invention uses lithospermum officinale and forsythia suspensa as the main drugs, honeysuckle, dandelion and phellodendron as the auxiliary drugs, and borneol and centipede as the assistant drugs, and the compatibility is reasonable. Compared with the currently available moist burn ointment, it has better healing and anti-inflammatory effects, can reduce the wound area faster, has a short healing period and a fast treatment process. BRIEF DESCRIPTION OF THE DRAWINGS
[0048] Figure 1 These are typical pictures of scalded skin wounds in each group of the present invention; in the figure, A-blank control group, B-model control group, C-positive control group, D-burn ointment group 1, E-burn ointment group 2, F-burn ointment group 3, G-burn ointment group 4, H-burn ointment group 5, I-burn ointment group 9, J-burn ointment group 10, K-compound phellodendron liquid coating.
[0049] Figure 2 These are typical pictures of scald skin pathology in each group of the present invention; in the figure, A-blank control group, B-model control group, C-positive control group, D-burn ointment group 1, E-burn ointment group 2, F-burn ointment group 3, G-burn ointment group 4, H-burn ointment group 5, I-burn ointment group 9, J-burn ointment group 10, K-compound phellodendron liquid coating.
[0050] Figure 3 These are typical pictures of scalded skin wounds in the burn ointment group 3 and the burn ointment group 4 of the present invention; in the figure, a-blank control group, b-model control group, c-positive control group, d-burn ointment group 3, and e-burn ointment group 6. DETAILED DESCRIPTION
[0051] The following non-limiting examples can enable those skilled in the art to more fully understand the present invention, but do not limit the present invention in any way. The following content is only an exemplary description of the scope of the present invention, and those skilled in the art can make various changes and modifications to the invention of the present invention based on the disclosed content, and they should also fall within the scope of the present invention.
[0052] In the present invention, unless otherwise specified, the numerical range "ab" represents an abbreviation of any real number combination between a and b, where a and b are real numbers. For example, the numerical range "5-10" means that all real numbers between "5-10" have been listed in this document, and "5-10" is just an abbreviation of these numerical combinations, such as 5, 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, 5.8, 5.9, 6, 7, 8, 9, 10 or any range therebetween.
[0053] The present invention is further described below by way of specific examples. Unless otherwise specified, the various chemical reagents used in the examples of the present invention are obtained through conventional commercial channels.
[0054] Example 1
[0055] A Chinese medicine composition for treating burns, comprising the following raw materials:
[0056] 40g of Lithospermum erythrorhizon, 40g of Forsythia suspensa, 20g of Honeysuckle, 20g of Taraxacum mongolicum, 20g of Phellodendron chinense, 1g of Centipede, and 5g of Borneol.
[0057] This embodiment also provides an ointment (referred to as burn ointment group 1) made from the above-mentioned Chinese medicine composition for treating burns, which is prepared by the following method:
[0058] S1. Preparation of Chinese medicine composition
[0059] (1) Take lithospermum officinale, add 6 times sesame oil, soak for 30 minutes, heat and extract at 150° C. for 10 minutes, filter, and obtain lithospermum officinale oil extract;
[0060] (2) Take Forsythia suspensa, Honeysuckle, Taraxacum officinale, Phellodendron chinense and Scolopendra subspinipes, add 8 times the amount of water, soak for 1 hour, heat under reflux at 100°C for 3 times, the first extraction is 1.5 hours, the second extraction is 1 hour, and the third extraction is 1 hour, filter, combine the filtrates, concentrate the filtrates to a clear paste with a relative density of about 1.08 (60°C), add ethanol to make the alcohol content reach 70%, let it stand for 24 hours, filter, recover the ethanol until there is no alcohol taste, and obtain the alcohol precipitation concentrate for standby use;
[0061] (3) Take borneol and crush it into the finest powder;
[0062] S2. Make into paste
[0063] Take 200g of lanolin and 15g of stearic acid glyceryl, heat to 80°C, add lithospermum oil extract after they are completely melted, and mix to obtain the oil phase; take 100g of polyethylene glycol 6000 and 50g of Tween 80, heat to 80°C, add alcohol precipitation concentrate after they are completely melted, and obtain the water phase; at 80°C, slowly add the water phase to the oil phase, stir, cool, add borneol powder, stir evenly, and obtain.
[0064] Example 2
[0065] Another Chinese medicine composition for treating burns comprises the following raw materials:
[0066] 50g of Lithospermum erythrorhizon, 50g of Forsythia suspensa, 30g of Honeysuckle, 30g of Taraxacum officinale, 30g of Phellodendron chinense, 1.5g of Centipede, and 10g of Borneol.
[0067] This example also provides an ointment (referred to as burn ointment group 2) made from the above-mentioned Chinese medicine composition for treating burns, and its preparation method is the same as that of Example 1.
[0068] Example 3
[0069] Another Chinese medicine composition for treating burns comprises the following raw materials:
[0070] 60g of Lithospermum officinale, 60g of Forsythia suspensa, 40g of Honeysuckle, 40g of Taraxacum mongolicum, 40g of Phellodendron chinense, 2.4g of Centipede, and 15g of Borneol.
[0071] This example also provides an ointment (referred to as burn ointment group 3) made from the above-mentioned Chinese medicine composition for treating burns, and its preparation method is the same as that of Example 1.
[0072] Example 4
[0073] Another Chinese medicine composition for treating burns comprises the following raw materials:
[0074] 70g of Lithospermum officinale, 70g of Forsythia suspensa, 50g of Honeysuckle, 50g of Phellodendron chinense, 50g of Taraxacum mongolicum, 20g of Borneolum Syntheticum, and 3.5g of Centipede.
[0075] This example also provides an ointment (referred to as burn ointment group 4) made from the above-mentioned Chinese medicine composition for treating burns, and its preparation method is the same as that of Example 1.
[0076] Example 5
[0077] Another Chinese medicine composition for treating burns comprises the following raw materials:
[0078] 80g of Lithospermum erythrorhizon, 80g of Forsythia suspensa, 60g of Honeysuckle, 60g of Taraxacum mongolicum, 60g of Phellodendron chinense, 4.0g of Scolopendra subspinipes, and 25g of Borneol.
[0079] This example also provides an ointment (referred to as burn ointment group 5) made from the above-mentioned Chinese medicine composition for treating burns, and its preparation method is the same as that of Example 1.
[0080] Example 6
[0081] Another Chinese medicine composition for treating burns has the same formula as that of Example 3.
[0082] This example also provides an ointment (referred to as burn ointment group 6) made from the above-mentioned Chinese medicine composition for treating burns. The preparation method thereof is basically the same as that of Example 1, except that there is no alcohol precipitation step in the extraction process of the Chinese medicine composition, that is, step (2) in the extraction process of the Chinese medicine composition is: take Fructus Forsythiae, Flos Lonicerae, Herba Taraxaci, Cortex Phellodendri and Scolopendra subspinipes, add 8 times the amount of water, soak for 1 hour, heat under reflux at 100°C for extraction, extract 3 times, the first extraction is 1.5 hours, the second extraction is 1 hour, the third extraction is 1 hour, filter, combine the filtrate, and concentrate the filtrate to a clear ointment with a relative density of about 1.08 (60°C) for use.
[0083] Example 7
[0084] A Chinese medicine composition for treating burns, whose formula is the same as that of Example 3.
[0085] This embodiment also provides an ointment made from the above-mentioned Chinese medicine composition for treating burns (referred to as burn ointment group 7), which is prepared by the following method:
[0086] S1. Preparation of Chinese medicine composition
[0087] (1) Take lithospermum officinale, add 5 times cottonseed oil, soak for 20 minutes, heat and extract at 160° C. for 5 minutes to obtain lithospermum officinale oil extract;
[0088] (2) Take Forsythia suspensa, Honeysuckle, Taraxacum officinale, Phellodendron chinense and Scolopendra subspinipes, add 6 times the amount of water, soak for 0.5 h, heat at 75°C for extraction, extract twice, the first extraction is 2 h, the second extraction is 1 h, filter, combine the filtrate, concentrate the filtrate to a clear paste with a relative density of about 1.06 (60°C), add ethanol to make the alcohol content reach 60%, let it stand for 20 h, filter, recover ethanol until there is no alcohol taste, and obtain the alcohol precipitate concentrate for use;
[0089] (3) Take borneol and crush it into powder;
[0090] S2. Make into paste
[0091] Take 90g paraffin and 6g stearic acid glyceryl, heat to 70℃, add lithospermum oil extract after they are completely melted, mix well to obtain the oil phase; take 45g glycerol and 12g Tween 80, heat to 70℃, add alcohol precipitation concentrate after they are completely melted, and obtain the water phase; at 70℃, slowly add the water phase to the oil phase, stir, cool, add borneol powder, stir well, and obtain.
[0092] Example 8
[0093] A Chinese medicine composition for treating burns, whose formula is the same as that of Example 3.
[0094] This embodiment also provides an ointment (referred to as burn ointment group 8) made from the above-mentioned Chinese medicine composition for treating burns, which is prepared by the following method:
[0095] S1. Preparation of Chinese medicine composition
[0096] (1) Take lithospermum officinale, add 10 times olive oil, soak for 40 minutes, heat and extract at 140° C. for 20 minutes to obtain lithospermum officinale oil extract;
[0097] (2) Take Forsythia suspensa, Honeysuckle, Taraxacum officinale, Phellodendron chinense and Scolopendra subspinipes, add 10 times the amount of water, soak for 1.5 hours, heat under reflux at 90°C for extraction, extract 3 times, the first extraction is 2 hours, the second extraction is 1 hour, and the third extraction is 0.5 hours, filter, combine the filtrate, concentrate the filtrate to a clear paste with a relative density of about 1.10 (60°C), add ethanol to make the alcohol content reach 80%, let it stand for 72 hours, filter, recover ethanol until there is no alcohol taste, and obtain the alcohol precipitate concentrate for standby use;
[0098] (3) Take borneol and crush it into the finest powder;
[0099] S2. Make into paste
[0100] Take 315g paraffin and 25g stearic acid glyceryl, heat to 90°C, and add lithospermum oil extract after they are completely melted, and mix to obtain the oil phase; take 160g glycerol and 80g Tween 80, heat to 90°C, and add alcohol precipitation concentrate after they are completely melted to obtain the water phase; at 90°C, slowly add the water phase to the oil phase, stir, cool, add borneol powder, and stir evenly to obtain.
[0101] Comparative Example 1
[0102] Another Chinese medicine composition for treating burns is different from Example 3 in that in this comparative example, honeysuckle is replaced by an equal amount of honeysuckle, and other components remain unchanged.
[0103] This comparative example also provides an ointment prepared from the above-mentioned Chinese medicine composition for treating burns (referred to as burn ointment group 9).
[0104] Comparative Example 2
[0105] Another Chinese medicine composition for treating burns is different from Example 3 in that no lithospermum officinale and borneol are added to this comparative example, and the other components remain unchanged.
[0106] This comparative example also provides an ointment prepared from the above-mentioned Chinese medicine composition for treating burns (referred to as burn ointment group 10).
[0107] Comparative Example 3
[0108] Another Chinese medicine composition for treating burns comprises the following raw materials:
[0109] Lithospermum 35g, Forsythia suspensa 35g, Honeysuckle 15g, Taraxacum mongolicum 15g, Phellodendron chinense 15g, Centipede 0.5g, Borneol 3g.
[0110] This comparative example also provides an ointment prepared from the above-mentioned Chinese medicine composition for treating burns (referred to as burn ointment group 11), and its preparation method is the same as that of Example 1.
[0111] Comparative Example 4
[0112] Another Chinese medicine composition for treating burns comprises the following raw materials:
[0113] 90g of Lithospermum officinale, 90g of Forsythia suspensa, 70g of Honeysuckle, 70g of Taraxacum mongolicum, 70g of Phellodendron chinense, 6g of Centipede, and 30g of Borneol.
[0114] This comparative example also provides an ointment prepared from the above-mentioned Chinese medicine composition for treating burns (referred to as burn ointment group 12), and its preparation method is the same as that of Example 1.
[0115] Comparative Example 5
[0116] Commercially available compound Phellodendron chinense liquid paint.
[0117] Test Example 1
[0118] 1. Experimental method: 6-8 week old SPF male SD rats (purchased from Jinan Pengyue Experimental Animal Breeding Co., Ltd.) were selected, 11 rats were not treated as blank control group, 12 rats were used as model control group, and the rest of the animals were divided into positive control group and experimental group (burn ointment, commercially available compound phellodendron liquid coating), with 11 rats in each group. The positive control group was commercially available moist burn ointment.
[0119] The rats in the model control group, positive control group and experimental group were modeled. The animals in each group were anesthetized about 24 hours before modeling, and the hair on both sides of the back of the animals to be scalded was shaved with a shaver. The remaining short hair was removed with depilatory cream to expose the skin. On the day of modeling, except for the blank control group, the rats in the modeling group were anesthetized and marked with a burn surface on the left and right sides of the back of the hair removal site. The scalding head (diameter 2.0 cm) of the scalding instrument was set to pressure: 0.5 kg; temperature: 75 ° C, time 10 s; after the temperature stabilized, the intended part of the rat's back was scalded, and the degree of scalding was deep II degree.
[0120] Drug administration was started immediately after scalding in each group. All experimental groups and the positive control group were evenly applied to the scalded area of the rats according to the dosage, 0.2 mL / scalded surface / time, twice a day, with an interval of not less than 5 hours. When administering, care should be taken to evenly apply each drug preparation to the wound surface with a thickness of less than 1 mm, and the drug was administered continuously for 7 days; the blank control group and the model control group were applied with 0.2 mL of 0.9% sodium chloride injection in the same way.
[0121] 2. Index detection:
[0122] 2.1 Wound area and wound healing rate:
[0123] The number of days of administration was recorded as TD, the first administration day was TD1, and so on. The wounds of rats were photographed once before the first administration of TD1, before the first administration of TD4, and before blood collection by autopsy. The parameters of each photo were fixed, and the wound area on the first day was used as the benchmark. The images were analyzed by Image J image processing software, the wound area was counted, and the wound healing rate was calculated. Wound healing rate (%) = (TD1 wound area - TDn wound area) ÷ TD1 wound area × 100%.
[0124] 2.2 Histopathology
[0125] About 16 hours after the last medication, after blood was taken from all the animals to be dissected, the right skin was removed and placed in 10% formaldehyde fixative for histopathological examination. The steps were as follows: each skin sample was cut longitudinally at the longest diameter of the wound surface, paraffin sections were prepared as usual, hematoxylin-eosin (HE) stained, observed under a microscope and photographed. Pathological diagnosis was based on the semi-quantitative standardized evaluation method of the histopathology of the skin wound healing model: each pathological section observed the skin structure, epithelial regeneration, granulation tissue, neutrophils, macrophages and other indicators, and the above indicators were analyzed for the evaluation of the main indicators of wound healing (horizontally). The specific scores of the histopathological scoring standard (horizontally) of the skin wound healing model are shown in Table 1.
[0126] Table 1 Histopathological scoring criteria (horizontal)
[0127]
[0128]
[0129] 3. Data processing and statistical methods
[0130] Excel spreadsheets were used to calculate the group mean and standard deviation of all numerical data (wound area, wound healing rate, histopathological score, etc.). No statistics were performed for general observation. SPSS Statistics 19 was used for statistical analysis of the data: Levene's test was used to test the homogeneity of variance. If the variance was homogeneous (P>0.05), one-way analysis of variance (ANOVA) was performed: when there was a statistical difference (P≤0.05), Dunnett t test was used to compare the differences between groups; if the variance was not homogeneous (P≤0.05), Kruskal-Wallis test was performed: when the difference was statistically significant (P≤0.05), Mann-Whitney U rank sum test (MW method) was used to compare the differences between groups. After calculating the Ridit value of the group level (stage) for samples of grade (histopathological longitudinal score) data, a non-parametric rank sum test (Kruskal-Wallis) was used. Intergroup differences were compared between the model control group, positive control group and experimental group, and all tests were two-sided tests with α = 0.05.
[0131] 4. Test results
[0132] 4.1 General physical signs observation
[0133] During the experiment, the animals in each group were generally in good condition and no obvious abnormalities were observed.
[0134] 4.2 Wound Observation and Wound Healing
[0135] The wound healing results are shown in Table 2 and Figure 1 .
[0136] Table 2. Wound area and wound healing rate (Mean±SD)
[0137]
[0138]
[0139] Note: * indicates P<0.05 compared with the model control group; ** indicates P<0.01 compared with the model control group; # indicates P<0.05 compared with the positive control group.
[0140] Macroscopic observation of the wound surface showed that in the blank control group, the skin surface of the animals was smooth, flesh-pink, and had no wound surface or scab.
[0141] In the model control group, before administration of TD1, the skin of the animal modeling site was white, and all the wounds were scabby from TD2 until the end of administration. All the scabby wounds of the animals in this group did not fall off, and only 11 animals had the scabby wound edges lifted.
[0142] In the positive control group, before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all the wounds were scabby. Until the end of administration, the scabs of 3 animals in this group partially fell off, and the scabs of 1 animal fell off completely. New skin was seen growing at the sites where the scabs fell off.
[0143] In burn ointment group 1, before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all wounds were scabby until the end of administration. The scabs of 5 animals in this group partially fell off, and new skin was seen growing at the site where the scabs fell off.
[0144] In burn ointment group 2, before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all the wounds were scabby until the end of administration. In this group, the scab partially fell off in one animal, and the scab completely fell off in another animal, and new skin was seen growing at the site where the scab fell off.
[0145] In burn ointment group 3, before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all the wounds were scabby. Until the end of administration, the scabs of 3 animals in this group partially fell off, and the scabs of 2 animals completely fell off. New skin was seen growing at the sites where the scabs fell off.
[0146] In burn ointment group 4, before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all wounds were scab-formed. Until the end of administration, the scabs of 7 animals in this group partially fell off, and the scabs of 1 animal completely fell off. New skin was seen growing at the site where the scabs fell off.
[0147] In burn ointment group 5, before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all wounds were scabby until the end of administration. The scab of one animal in this group partially fell off, and new skin was seen growing at the site where the scab fell off.
[0148] In burn ointment group 9, before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all the wounds were scabby. Until the end of administration, the scabs of 4 animals in this group partially fell off, and the scabs of 2 animals completely fell off. New skin was seen growing at the sites where the scabs fell off.
[0149] In the burn ointment group 10, before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all the wounds were scabby until the end of administration. The scabs of 2 animals in this group partially fell off, and new skin was seen growing at the site where the scabs fell off.
[0150] In the compound phellodendron liquid coating group, before administration of TD1, the skin of the animal modeling site was white, and from TD2 onwards, all the wounds were scabby until the end of administration. The scab of one animal in this group partially fell off, and new skin was seen growing at the site where the scab fell off.
[0151] The results of wound area measurement showed that at TD4, the wound area and wound healing rate of the animals in the positive control group and burn ointment groups showed an improvement trend compared with the model control group (P>0.05). At TD8, the wound healing rates of the positive control group and burn ointment groups 1, 2, 4, and 9 were significantly higher than those of the model control group (P<0.05 or P<0.01), and the wound healing rate of burn ointment group 4 was significantly higher than that of the positive control group (P<0.05).
[0152] 4.2 Histopathology
[0153] The results are shown in Table 3 and Appendix Figure 2 .
[0154] Table 3. Histopathological scores (horizontal, Mean + SD)
[0155] Group Epithelial regeneration Granulation tissue Neutrophils Macrophages Blank control group 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 Model control group 1.92±1.44 0.25±0.45 1.42±1.51 0.00±0.00 Positive control group 1.64±1.43 0.82±1.33 1.36±0.81 0.00±0.00 Burn ointment 1 set 2.73±1.62 1.27±0.47** 0.82±0.75 0.00±0.00 Burn ointment 2 sets 2.09±2.02 1.55±0.69**# 1.00±1.00 0.00±0.00 Burn ointment 3 sets 3.00±1.34 1.64±0.92**# 0.91±0.94 0.00±0.00 Burn ointment 4 sets 1.27±1.56 1.82±0.75**# 1.36±0.67 0.00±0.00 Burn ointment 5 sets 2.82±1.47 1.36±0.50** 0.73±0.79 0.00±0.00 Burn ointment 9 sets 1.64±1.75 1.27±0.47** 1.55±1.51 0.00±0.00 Burn ointment 10 sets 2.20±1.40 1.40±0.97** 1.50±1.08 0.00±0.00 Compound Phellodendron liquid paint 1.64±1.43 1.82±0.75**# 1.36±1.03 0.00±0.00
[0156] Note: * indicates P<0.05 compared with the model control group; ** indicates P<0.01 compared with the model control group; # indicates P<0.05 compared with the positive control group.
[0157] The results showed that the skin wounds of the rats in the model control group were not completely healed, with necrosis and inflammatory cell infiltration in the epidermis and superficial dermis, granulation tissue in the superficial dermis, scabs formed by exudates, and epidermal necrotic layer attached. The skin wounds of the rats in the positive control group were not completely healed, partially covered by new epidermis, granulation tissue in the superficial dermis, scabs formed by exudates, and epidermal necrotic layer attached. Among the burn ointment groups, group 3 had the best skin healing, which was specifically manifested in that the skin wounds were completely covered by new epidermis, granulation tissue in the superficial dermis, scabs formed by exudates, and epidermal necrotic layer attached.
[0158] The granulation tissue scores of all burn ointment groups and compound phellodendron liquid coating were significantly higher than those of the model control group (P<0.01), and the granulation tissue scores of burn ointment groups 2, 3, 4 and compound phellodendron liquid coating were significantly higher than those of the moist burn ointment control group (P<0.05). The epithelial regeneration scores of burn ointment groups 3, 10, 1, 5 showed an increasing trend compared with the model control group (P>0.05). The neutrophil scores of burn ointment groups 3, 2, 1, 5 showed a decreasing trend compared with the model control group (P>0.05).
[0159] Based on the above experimental results, the conclusions are as follows:
[0160] The results of naked eye observation showed that the burn ointment groups 1, 2, 4 and 9 were more effective in reducing the wound area.
[0161] The results of histopathological examination showed that the epithelial regeneration indexes in burn ointment groups 1, 3, 5 and 10 showed a more obvious improvement trend; burn ointment groups 2-4 and compound phellodendron liquid coating had a more obvious effect on granulation tissue score than other groups; burn ointment groups 1-3 and 5 had a more obvious trend of decreasing neutrophils. Based on the results of pathological examination, burn ointment groups 1-3 and 5 had a certain effect on deep wound healing.
[0162] In addition, the compound phellodendron liquid coating only had a high score for granulation tissue, indicating that it had a certain anti-inflammatory effect, but had no effect on the surface repair and deep repair of trauma; the burn ointment group 9 only had a significant improvement on the surface of trauma repair, had no effect on deep repair, and had basically no anti-inflammatory effect; the burn ointment group 10 had a certain deep repair effect, but the effect was not outstanding, and had basically no effect on surface repair and anti-inflammatory.
[0163] Based on the macroscopic observation and histopathological results, burn ointment groups 1-5 had certain effects on the repair of wounds caused by burns. Among them, burn ointment groups 4 and 5 had more obvious improvements on the surface and deep-level indicators of wound repair, respectively; burn ointment group 3 had a more prominent effect on the deep-level repair of wounds, and burn ointment group 1 was better than the positive control group in all indicators of wound repair.
[0164] Test Example 2
[0165] In order to verify the influence of the alcohol precipitation step in the extraction process of the Chinese medicine composition, the present invention also conducted a rat test on the burn ointment group 3 and the burn ointment group 6 for wound healing, and the steps were as follows:
[0166] SPF male SD rats that passed the quarantine were selected, and 6 rats were selected as the normal control group without treatment. The rest of the animals were modeling groups to prepare a rat deep II degree burn model. The animals with successful modeling were selected and randomly divided into model control group, positive control group, 3 groups of Phellodendron burn ointment, and 6 groups of Phellodendron burn ointment according to the wound area, with 6 rats in each group. The drug was administered on the day of grouping. Each drug-administered group was evenly applied to the scalded part of the rat according to the dose, with a thickness of less than 1mm. The dosage was about 150mg / rat / time. The normal control group and the model control group were given 150μl / rat / time of normal saline, twice a day, for 17 consecutive days. The body weight was tested once a week, and the wound of the rat was photographed once every 3 days before and after drug administration. The images were analyzed by Image-Pro Plus 6.0 image processing software, the wound area was counted, and the wound healing rate was calculated.
[0167] The measured results are shown in Tables 4, 5 and Figure 3 shown.
[0168] Table 4. Wound surface area ( Unit: cm 2 )
[0169]
[0170]
[0171] Note: ## indicates that compared with the normal control group, P<0.01; * indicates that compared with the model control group, P<0.05; ** indicates that compared with the model control group, P<0.01.
[0172] Table 5. Wound healing rate ( unit:%)
[0173] Group D3 D6 D9 D12 D15 After the last dose Normal control group 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 Model control group 17.31±4.16 24.46±6.45 33.97±7.30 43.47±9.41 57.30±7.78 68.91±8.19 Positive control group 15.55±9.98 25.18±5.85 35.59±6.96 52.06±10.83 67.83±8.68 77.89±7.92* Burn ointment 3 sets 21.03±5.84 28.90±5.36 42.92±3.77* 58.13±4.21* 74.55±3.66* 82.42±3.66** Burn ointment 6 sets 19.95±11.69 29.52±9.85 41.47±7.33 55.58±11.60* 71.93±5.77 82.51±4.89**
[0174] Note: * indicates P<0.05 compared with the model control group; ** indicates P<0.01 compared with the model control group.
[0175] The results of wound area showed that compared with the normal control group, the wound area of the model control group increased significantly after administration on D3 (P<0.01). Compared with the model control group, the wound area of burn ointment group 3 decreased significantly on D12 (P<0.05), and there was no significant difference in the wound area of the other groups, but all showed a decreasing trend; after the last administration, the wound area of the positive control group, burn ointment group 3, and burn ointment group 6 decreased significantly (P<0.05 or 0.01).
[0176] The results of wound healing rate show that, compared with the model control group, on D9, the wound healing rate of burn ointment group 3 was significantly increased; on D12, the wound healing rates of burn ointment groups 3 and 6 were significantly increased. After the last administration, the wound healing rates of the positive control group, burn ointment group 3, and burn ointment group 6 were all significantly increased (P<0.05 or 0.01); it can also be seen that in the early stage of administration, the wound healing effect of burn ointment group 3 was better than that of burn ointment group 6.
[0177] Comprehensively judging from the wound area and wound healing rate, it can be seen that both burn ointment groups 3 and 6 can significantly improve the wound healing after scald and promote wound healing. The comprehensive evaluation results of the efficacy are: burn ointment group 3 > burn ointment group 6 > positive control group.
[0178] The above description of the embodiments is to facilitate the understanding and use of the invention by those skilled in the art. It is obvious that those skilled in the art can easily make various modifications to these embodiments and apply the general principles described herein to other embodiments without creative work. Therefore, the present invention is not limited to the above embodiments, and improvements and modifications made by those skilled in the art based on the disclosure of the present invention without departing from the scope of the present invention should be within the scope of protection of the present invention.
Claims
1. A Chinese medicine composition for treating burns, It is characterized in that Contains comfrey, forsythia, honeysuckle, dandelion, phellodendron, centipede and borneol.
2. The Chinese medicine composition according to claim 1, It is characterized in that The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 40-85 parts by weight of lithospermum officinale, 40-85 parts by weight of forsythia, 20-65 parts by weight of honeysuckle, 20-65 parts by weight of dandelion, 20-65 parts by weight of phellodendron, 1-5 parts by weight of centipede and 5-25 parts by weight of borneol.
3. A method for preparing the Chinese medicine composition according to claim 1 or 2, It is characterized in that The following steps are involved: (1) soaking Lithospermum officinale in oil and heating for extraction to obtain Lithospermum officinale extract; (2) taking Forsythia suspensa, honeysuckle, dandelion, Phellodendron chinense and Scolopendra subspinipes, soaking them in water, heating and extracting them to obtain an extract; (3) Add the extract obtained in step (2) to the lithospermum officinale extract obtained in step (1), add borneol, and mix well.
4. The method for preparing the Chinese medicine composition according to claim 3, It is characterized in that In step (1), the oil is selected from at least one of sesame oil, peanut oil, cottonseed oil and olive oil.
5. The method for preparing the Chinese medicine composition according to claim 3, It is characterized in that In step (1), the amount of the oil is 5-10 times the mass of Lithospermum officinale; the heating extraction time is 5-20 minutes, and the heating extraction temperature is 140-160°C.
6. The method for preparing the Chinese medicine composition according to claim 3, It is characterized in that In step (2), during the heating extraction process, the extraction times are 2-3 times, and the extraction time for each time is 0.5-2h.
7. The method for preparing the Chinese medicine composition according to claim 3, It is characterized in that The step (2) also includes an alcohol precipitation step; the alcohol precipitation step includes: concentrating the extract into a clear paste, adding ethanol to the clear paste to make the alcohol content reach 60-80%, leaving it for 20-72 hours, filtering, and recovering the ethanol until there is no alcohol taste, thereby obtaining an alcohol precipitation concentrate.
8. An external preparation for treating burns, It is characterized in that The external preparation for treating burns comprises the Chinese medicine composition according to claim 1 or 2.
9. The external preparation according to claim 8, It is characterized in that The dosage form of the external preparation is at least one of an ointment, a liniment, a paint, a gel, a film coating, a gel patch, and a lotion.
10. The external preparation according to claim 8, It is characterized in that The external preparation further comprises at least one of a pharmaceutically acceptable excipient, a matrix and a carrier.
Citation Information
Patent Citations
Burn tincture as well as preparation method and application thereof
CN103446290A
Traditional Chinese medicine composition for controlling wound inflammation
CN107126464A
Applications of centipede extract and effective part in wound surface repair fields
CN107753521A
Scald oil and preparation method thereof
CN112336805A
Chinese medicine preparation for sore, ulcer and infection caused by external wound and preparation method
CN1169863A
